Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 9277

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.16, p 0.682). This receipt's hash covers every field on it, plus the hash of receipt 9276, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 9277
    25 Oct 2026, 02:32 UTC

    ZC3H12A

    dopamine neurons, braak

    predictionZC3H12A in dopamine neurons tracks Braak Lewy-body stage

    registered9232fd020cab9d47

    discovery-0.16 p=0.682 n=9

    replication-0.37 p=0.334 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.16, p 0.682)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    b1e3c9c7b6fbeca923fd15dd…
    follows 28f2728cf990…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 9277: ZC3H12A in dopamine neurons, braak

power
full sample -0.23 (p 0.355, n 18), 95% CI -0.63 to +0.26. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.21 (p 0.413, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.32 (p 0.198, n 18). could be the mix.
skeptic
leave-one-out range -0.36 to -0.13, sign flips 0; without severely affected donors -0.23 (p 0.355, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for ZC3H12A in dopamine neurons.

case closed: nothing better to follow up.